AlfreyA.C., MishellJ.M., BurksJ.Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Int Organs1972; 18: 257–61.
AlfreyA.C.. Aluminum intoxication. New Engl J Med1984; 17: 1113–4.
7.
OttS.M.. Aluminum-related o-steomalacia. Int J Artif Int Organs1983; 6: 173–5.
8.
O'HareJ.A., MurnaghanD.J.. Reversal of aluminum induced hemodialysis anemia by low-aluminum dialysate. New Engl J Med1982; 306: 654–6.
9.
AltmanP., Al-SalihiF., ButterK.Serum aluminum levels and erythrocyte dihy-droopteridine reductase activity in patients on hemodialysis. New Engl J Med1987; 317: 80–4.
BakirA.A., HryhorczukD.O., BermanE., DuneaG.. Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients. Trans Am Soc Artif Intern Organs1986; 32: 171–6.
12.
MahurkarS.D., MeyersL., CohenJ., KamathV.K., DuneaG.. Electroencephalographic and radionuclide studies in dialysis dementia. Kidney Int1978; 13: 306–15.
13.
Noriega-SanchezA., Martinez MoldonadoM., HaiffeR.M.. Clinical and electroencephalographic changes in progressive uremic encephalopathy. Neurology1978; 28: 667–9.
14.
ClarksonE.M., HinsonL.W.V., BaileyR.R.The effect of aluminum hydroxide on calcium, phosphorus, and aluminum balances, the serum parathyroid concentration and the aluminum content of bone in patients with chronic renal failure. Clin Sci1972; 43: 519–31.
15.
KaehneyW.D., HeggA.P., AlfreyA.C.. Gastrointestinal ab-sorptin of aluminum from aluminum-containing antacids. New Eng J Med1977; 296: 1389–90.
16.
MassselotJ.P., AdhemarJ.P., JandonM.C., KleinknechtD., GalliA.. Reversible dialysis encephalopathy: role for aluminum-containing gels. Lancet1970; 2: 1386–7.
17.
NathanE., PedersenS.E.. Dialysis encephalopathy in a non-dialyzed uremic boy treated with aluminum hydroxide orally. Acta Paediat Scand1980; 69: 793–6.
18.
SedmanAB, MillerN.L., Wara-dyB.A., LumG.M., AlfreyA.C.. Aluminum loading in children with chronic renal failure. Kidney Int1984; 26: 201–4.
19.
BakirA.A., HryhorczukD.O., HesslS.M., BermanE., SpenglerR., DuneaG.. Hyperalumine-mia and fatal encephalopathy in azotemic patients taking aluminum hydroxide: the influence of age and citrate intake (Abstract). 10th Internat Congr Nephrol1987; 3.
20.
BakirA.A., HryhorczukD.O., AhmedS.Hyperalumine-mia in renal failure: the influence of age and citrate intake. Clin Nephrol1989; 31: 40–4.
21.
SlaninaP., FalkenbornY., FrechW., CedergrenA.. Aluminium concentrations in the brain and bone of rats fed citric acid, aluminum citrate or aluminum hydroxide. Fed Chem Toxic1984; 22: 391–7.
22.
SlaninaP., FrechW., Bernhar-dsonA., CedergrenA., PattersonP.. Influence of dietary factors on aluminum absorption and retention in the brain and bone of rats. Acta Pharmacol Toxicol1985; 56: 331–6.
23.
PattnaikR., PaniS.. Studies on the citrate complex of aluminum (III). J Indian Chem Soc1961; 38: 379–84.
24.
TrappG.A.. Interactions of aluminum with cofactors, enzymes, and other proteins. Kidney Int1986; 29(Suppl 18): 12–6.
25.
KingS., SavoryJ., WillsM.. Aluminum distribution in serum following hemodialysis. Annals Clin Lab1982; 12: 143–9.
26.
ThomasW., MeyerJ.. Aluminum-induced osteomalacia: an explanation. Am J Nephrol1984; 4: 201–3.
27.
SalninaP., FrechW., EkstromL., LoofL., SlorachS., CedergrenA.. Dietary citric acid enhances absorption of aluminum in antacids. Clin Chem1986; 32: 539–41.
Crapper McLachlanD.R.. Aluminum and Alzheimer's disease. Neurobiol of Aging1986; 7: 525–32.
33.
SherrardD.J., WalkerJ.V., Boy-kinJ.L.. Precipitating of dialysis dementia by deferroxamine treatment of aluminum-related bone disease. Am J Kidney Dis1988; 12: 126–30.
34.
AndressD.L., KoppJ.B., Malo-neyN.A., CoburnJ.W., SherrardD.J.. Early deposition of aluminum in bone in diabetic patients on hemodialysis. New Eng J Med1987; 316: 292–6.
35.
CoburnJ.W., RobertsonJ.A., NorrisK.C., SaluskyI.B., GoodmanW.G.. Effect of ranitidine on aluminum absorption in man (Abstract). Am Soc Nephrol1988; 250.
36.
FournierA., MoriniereP., Se-bertJ.L.Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia. Kidney Int1986; 29(Suppl 18): 114–9.
